Literature DB >> 18426996

Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection.

Renate Schnabel1, Martin G Larson, Josée Dupuis, Kathryn L Lunetta, Izabella Lipinska, James B Meigs, Xiaoyan Yin, Jian Rong, Joseph A Vita, Christopher Newton-Cheh, Daniel Levy, John F Keaney, Ramachandran S Vasan, Gary F Mitchell, Emelia J Benjamin.   

Abstract

Inflammation causes vascular dysfunction and perpetuates proatherosclerotic processes. We hypothesized that a broad panel of inflammatory biomarkers and single nucleotide polymorphisms in inflammatory genes is associated with vascular stiffness. We assessed 12 circulating inflammatory biomarkers (C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase-A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, osteoprotegerin, P-selectin, and tumor necrosis factor receptor-II) in relation to tonometry variables (central pulse pressure, mean arterial pressure, forward pressure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and augmentation index) measured in 2409 Framingham Heart Study participants (mean age: 60 years; 55% women; 13% ethnic/racial minorities). Single nucleotide polymorphisms (n=2195) in 240 inflammatory candidate genes were related to tonometry measures in 1036 white individuals. In multivariable analyses, biomarkers explained <1% of any tonometry measure variance. Applying backward elimination, markers related to tonometry (P<0.01) were as follows: tumor necrosis factor receptor-II (inversely) with mean arterial pressure; C-reactive protein (positively) and lipoprotein-associated phospholipase-A2 (inversely) with reflected pressure wave; and interleukin-6 and osteoprotegerin (positively) with carotid-femoral pulse wave velocity. In genetic association analyses, lowest P values (false discovery rate <0.50) were observed for rs10509561 (FAS), P=6.6x10(-5) for central pulse pressure and rs11559271 (ITGB2), P=1.1x10(-4) for mean arterial pressure. These data demonstrate that, in a community-based sample, circulating inflammatory markers tumor necrosis factor receptor-II (mean arterial pressure), C-reactive protein, lipoprotein-associated phospholipase-A2 activity (reflected pressure wave), interleukin-6, and osteoprotegerin (carotid-femoral pulse wave velocity) were significantly but modestly associated with measures of arterial stiffness and wave reflection. Additional studies are needed to determine whether variation in inflammatory marker genes is associated with tonometry measures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426996      PMCID: PMC2892983          DOI: 10.1161/HYPERTENSIONAHA.107.105668

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  47 in total

Review 1.  Arterial stiffness and wave reflection in hypertension: pathophysiologic and therapeutic implications.

Authors:  Gary F Mitchell
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

2.  TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study.

Authors:  M P S Sie; F U S Mattace-Raso; A G Uitterlinden; P P Arp; A Hofman; A P G Hoeks; R S Reneman; R Asmar; C M van Duijn; J C M Witteman
Journal:  J Hum Hypertens       Date:  2007-03-15       Impact factor: 3.012

3.  Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals.

Authors:  Charalambos Vlachopoulos; Ioanna Dima; Konstantinos Aznaouridis; Carmen Vasiliadou; Nikolaos Ioakeimidis; Constadina Aggeli; Marina Toutouza; Christodoulos Stefanadis
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

4.  Arterial stiffness is related to systemic inflammation in essential hypertension.

Authors:  Azra Mahmud; John Feely
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

5.  Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study.

Authors:  A L Jefferson; J M Massaro; P A Wolf; S Seshadri; R Au; R S Vasan; M G Larson; J B Meigs; J F Keaney; I Lipinska; S Kathiresan; E J Benjamin; C DeCarli
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

6.  Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.

Authors:  S M Kim; J Lee; O H Ryu; K W Lee; H Y Kim; J A Seo; S G Kim; N H Kim; S H Baik; D S Choi; K M Choi
Journal:  Clin Endocrinol (Oxf)       Date:  2005-11       Impact factor: 3.478

7.  C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community.

Authors:  Iftikhar J Kullo; James B Seward; Kent R Bailey; Lawrence F Bielak; Brandon R Grossardt; Patrick F Sheedy; Patricia A Peyser; Stephen T Turner
Journal:  Am J Hypertens       Date:  2005-08       Impact factor: 2.689

8.  Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects.

Authors:  Y Saijo; M Utsugi; E Yoshioka; N Horikawa; T Sato; Y Y Gong; R Kishi
Journal:  J Hum Hypertens       Date:  2005-11       Impact factor: 3.012

9.  Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients.

Authors:  Costas Tsioufis; Kyriakos Dimitriadis; Maria Selima; Costas Thomopoulos; Costas Mihas; Ioannis Skiadas; Dimitrios Tousoulis; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Eur Heart J       Date:  2007-04-19       Impact factor: 29.983

Review 10.  Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials.

Authors:  Dorothea Nitsch; Mariam Molokhia; Liam Smeeth; Bianca L DeStavola; John C Whittaker; David A Leon
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

View more
  64 in total

1.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

2.  Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.

Authors:  Gary F Mitchell; Germaine C Verwoert; Kirill V Tarasov; Aaron Isaacs; Albert V Smith; Ernst R Rietzschel; Toshiko Tanaka; Yongmei Liu; Afshin Parsa; Samer S Najjar; Kevin M O'Shaughnessy; Sigurdur Sigurdsson; Marc L De Buyzere; Martin G Larson; Mark P S Sie; Jeanette S Andrews; Wendy S Post; Francesco U S Mattace-Raso; Carmel M McEniery; Gudny Eiriksdottir; Patrick Segers; Ramachandran S Vasan; Marie Josee E van Rijn; Timothy D Howard; Patrick F McArdle; Abbas Dehghan; Elizabeth S Jewell; Stephen J Newhouse; Sofie Bekaert; Naomi M Hamburg; Anne B Newman; Albert Hofman; Angelo Scuteri; Dirk De Bacquer; Mohammad Arfan Ikram; Bruce M Psaty; Christian Fuchsberger; Matthias Olden; Louise V Wain; Paul Elliott; Nicholas L Smith; Janine F Felix; Jeanette Erdmann; Joseph A Vita; Kim Sutton-Tyrrell; Eric J G Sijbrands; Serena Sanna; Lenore J Launer; Tim De Meyer; Andrew D Johnson; Anna F C Schut; David M Herrington; Fernando Rivadeneira; Manuela Uda; Ian B Wilkinson; Thor Aspelund; Thierry C Gillebert; Luc Van Bortel; Emelia J Benjamin; Ben A Oostra; Jingzhong Ding; Quince Gibson; André G Uitterlinden; Gonçalo R Abecasis; John R Cockcroft; Vilmundur Gudnason; Guy G De Backer; Luigi Ferrucci; Tamara B Harris; Alan R Shuldiner; Cornelia M van Duijn; Daniel Levy; Edward G Lakatta; Jacqueline C M Witteman
Journal:  Circ Cardiovasc Genet       Date:  2011-11-08

3.  Inflammatory markers and neuropsychological functioning: the Framingham Heart Study.

Authors:  Angela L Jefferson; Joseph M Massaro; Alexa S Beiser; Sudha Seshadri; Martin G Larson; Philip A Wolf; Rhoda Au; Emelia J Benjamin
Journal:  Neuroepidemiology       Date:  2011-07-13       Impact factor: 3.282

4.  Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification.

Authors:  Laure Joly; Wassila Djaballah; Gregory Koehl; Damien Mandry; Gilles Dolivet; Pierre-Yves Marie; Athanase Benetos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-30       Impact factor: 9.236

5.  Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.

Authors:  Thais Coutinho; Stephen T Turner; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2011-10-20       Impact factor: 2.689

6.  Arterial stiffness in mild-to-moderate CKD.

Authors:  Ashish Upadhyay; Shih-Jen Hwang; Gary F Mitchell; Ramachandran S Vasan; Joseph A Vita; Plamen I Stantchev; James B Meigs; Martin G Larson; Daniel Levy; Emelia J Benjamin; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

7.  Galectin 3 and incident atrial fibrillation in the community.

Authors:  Jennifer E Ho; Xiaoyan Yin; Daniel Levy; Ramachandran S Vasan; Jared W Magnani; Patrick T Ellinor; David D McManus; Steven A Lubitz; Martin G Larson; Emelia J Benjamin
Journal:  Am Heart J       Date:  2014-03-01       Impact factor: 4.749

8.  Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice.

Authors:  Bing Du; An Ouyang; Jason S Eng; Bradley S Fleenor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

Review 9.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.

Authors:  Anthony J Donato; Daniel R Machin; Lisa A Lesniewski
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

10.  The association between sleep-disordered breathing and aortic stiffness in a community cohort.

Authors:  Hassan A Chami; Ramachandran S Vasan; Martin G Larson; Emelia J Benjamin; Gary F Mitchell; Daniel J Gottlieb
Journal:  Sleep Med       Date:  2015-11-27       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.